Jaguar Health, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for JAGX, updated each market day.
JAGX AI Sentiment
AI predicts Jaguar Health, Inc. stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Jaguar Health, Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
Sector
Exchange
Market Cap
$4,706,905
Cap Tier
Employees
47
Headquarters
SAN FRANCISCO, CA
Listed Since
May 13, 2015
Website
JAGX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
JAGX Volatility
Jaguar Health, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
